Hong Kong · Delayed Price · Currency is HKD Kontafarma China Holdings Company Description
Kontafarma China Holdings Limited, an investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediate in Mainland China, Singapore, Taiwan, and internationally.
It operates through Pharmaceutical Business and Fitness Business segments. The company offers prescription drugs, including chemical drugs and prescribed traditional Chinese medicines; operates fitness and yoga centers, as well as franchise business; and provides management and consultation services for fitness and health activities.
It also offers corporate advisory services; and researches and develops medical products. The company was formerly known as Tongfang Kontafarma Holdings Limited and changed its name to Kontafarma China Holdings Limited in September 2022.
The company was incorporated in 2011 and is headquartered in Wan Chai, Hong Kong. Kontafarma China Holdings Limited is a subsidiary of China Health Management Investment Limited.
| Country | Cayman Islands |
| Founded | 2011 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 655 |
| CEO | Feifei Wang |
Contact Details
Address: Sun Hung Kai Centre Wan Chai Hong Kong | |
| Phone | 852 2731 6500 |
| Website | kontafarma.com.hk |
Stock Details
| Ticker Symbol | 1312 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | HKD |
| ISIN Number | KYG8918D1088 |
| SIC Code | 3241 |
Key Executives
| Name | Position |
|---|---|
| Feifei Wang | Executive Chairman and President |
| Zixiu Guo | Financial Controller and Executive Director |
| Jiankun Liu | Executive Director |
| Jie Zhang | Chief Operating Officer |
| Lok Tung Chan | Company Secretary |